Challenges to Evidence Synthesis and Identification of Data Gaps in Human Biomonitoring.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
10 03 2021
Historique:
received: 30 01 2021
revised: 05 03 2021
accepted: 07 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 27 4 2021
Statut: epublish

Résumé

The increasing number of human biomonitoring (HBM) studies undertaken in recent decades has brought to light the need to harmonise procedures along all phases of the study, including sampling, data collection and analytical methods to allow data comparability. The first steps towards harmonisation are the identification and collation of HBM methodological information of existing studies and data gaps. Systematic literature reviews and meta-analyses have been traditionally put at the top of the hierarchy of evidence, being increasingly applied to map available evidence on health risks linked to exposure to chemicals. However, these methods mainly capture peer-reviewed articles, failing to comprehensively identify other important, unpublished sources of information that are pivotal to gather a complete map of the produced evidence in the area of HBM. Within the framework of the European Human Biomonitoring Initiative (HBM4EU) initiative-a project that joins 30 countries, 29 from Europe plus Israel, the European Environment Agency and the European Commission-a comprehensive work of data triangulation has been made to identify existing HBM studies and data gaps across countries within the consortium. The use of documentary analysis together with an up-to-date platform to fulfil this need and its implications for research and practice are discussed.

Identifiants

pubmed: 33802154
pii: ijerph18062830
doi: 10.3390/ijerph18062830
pmc: PMC8000824
pii:
doi:

Substances chimiques

Environmental Pollutants 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom

Références

Int J Hyg Environ Health. 2007 May;210(3-4):201-28
pubmed: 17376741
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Syst Rev. 2016 Feb 10;5:28
pubmed: 26864942
Br J Sports Med. 2017 Oct;51(20):1456-1458
pubmed: 28223307
Eval Health Prof. 2002 Mar;25(1):76-97
pubmed: 11868447
Int J Epidemiol. 2017 Feb 1;46(1):103-105
pubmed: 27272186
Anesth Analg. 2016 Oct;123(4):812-3
pubmed: 27636569
Cochrane Database Syst Rev. 2011 Nov 09;(11):MR000027
pubmed: 22071866
PLoS One. 2008 Aug 28;3(8):e3081
pubmed: 18769481
IARC Monogr Eval Carcinog Risks Hum. 1994;60:389-433
pubmed: 7869577
J Toxicol Environ Health B Crit Rev. 2019;22(5-6):131-156
pubmed: 31543064
Int J Hyg Environ Health. 2019 Jun;222(5):727-737
pubmed: 31176761
Emerg Themes Epidemiol. 2015 Sep 30;12:14
pubmed: 26425136
Infect Control Hosp Epidemiol. 1996 Apr;17(4):262-6
pubmed: 8935735
Environ Int. 2019 Sep;130:104871
pubmed: 31254867
J Evid Based Med. 2017 Aug;10(3):233-240
pubmed: 28857505
Milbank Q. 2016 Sep;94(3):485-514
pubmed: 27620683
Int J Hyg Environ Health. 2014 Jul;217(6):653-61
pubmed: 24405937
Int J Sports Phys Ther. 2012 Oct;7(5):493-503
pubmed: 23091781
Hippokratia. 2010 Dec;14(Suppl 1):29-37
pubmed: 21487488
Int J Ment Health Syst. 2010 Dec 21;4:33
pubmed: 21176157
Med Inform Internet Med. 2001 Jul-Sep;26(3):203-18
pubmed: 11706930
Environ Health Perspect. 2014 Jul;122(7):711-8
pubmed: 24755067
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
Int J Epidemiol. 2001 Feb;30(1):12-4
pubmed: 11171841
Int J Hyg Environ Health. 2012 Feb;215(2):172-5
pubmed: 21940209
JAMA. 1993 Jun 2;269(21):2749-53
pubmed: 8492400
Intensive Care Med. 2018 Apr;44(4):518-520
pubmed: 29663048
Ann Intern Med. 2010 Jun 1;152(11):726-32
pubmed: 20335313
Res Synth Methods. 2014 Sep;5(3):221-34
pubmed: 26052848

Auteurs

Ana Virgolino (A)

Environmental Health Behaviour Lab, Instituto de Saúde Ambiental, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Osvaldo Santos (O)

Environmental Health Behaviour Lab, Instituto de Saúde Ambiental, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.
Unbreakable Idea Research, Lda, 2550-426 Painho, Portugal.

Joana Costa (J)

Environmental Health Behaviour Lab, Instituto de Saúde Ambiental, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Mónica Fialho (M)

Environmental Health Behaviour Lab, Instituto de Saúde Ambiental, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.

Ivo Iavicoli (I)

Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.

Tiina Santonen (T)

Finnish Institute of Occupational Health, 00032 Työterveyslaitos, Finland.

Hanna Tolonen (H)

Department of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), 00300 Helsinki, Finland.

Evangelia Samoli (E)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 115 27 Athens, Greece.

Klea Katsouyanni (K)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 115 27 Athens, Greece.

Georgios Baltatzis (G)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 115 27 Athens, Greece.

Flavia Ruggieri (F)

Department of Environment and Health, National Institute for Health, 00161 Rome, Italy.

Annalisa Abballe (A)

Department of Environment and Health, National Institute for Health, 00161 Rome, Italy.

Ida Petrovičová (I)

Department of Zoology and Anthropology, Constantine the Philosopher University in Nitra, 949 74 Nitra, Slovakia.

Branislav Kolena (B)

Department of Zoology and Anthropology, Constantine the Philosopher University in Nitra, 949 74 Nitra, Slovakia.

Miroslava Šidlovská (M)

Department of Zoology and Anthropology, Constantine the Philosopher University in Nitra, 949 74 Nitra, Slovakia.

Carla Ancona (C)

Department of Epidemiology, Local Health Authority Rome E, 00147 Rome, Italy.

Ivan Eržen (I)

Public Health School, National Institute of Public Health, 1000 Ljubljana, Slovenia.

Ovnair Sepai (O)

Public Health England, Harwell Campus, Chilton, Didcot OX 11 0RQ, UK.

Argelia Castaño (A)

CNSA, Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain.

Marike Kolossa-Gehring (M)

German Environment Agency, 14195 Berlin, Germany.

Ulrike Fiddicke (U)

German Environment Agency, 14195 Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH